Recombinant Human Albumin Injection (Oryza Sativa): A Breakthrough for Hypoalbuminemia in Cirrhosis
In the field of modern hepatology, cirrhosis continues to pose significant challenges, particularly when accompanied by hypoalbuminemia (serum albumin levels ≤30 g/L), which can lead to complications like ascites and edema, drastically affecting patients' quality of life. Traditional human serum albumin (HSA) derived from plasma has long been the standard treatment, but it faces limitations...
0 التعليقات 0 المشاركات 7 مشاهدة 0 معاينة
SMG https://sharemeglobal.com